• Our study established a prognostic and immunotherapeutic predictive model, the tumor immune cell score (TICS), by differentiating cell origins in lung adenocarcinoma (LUAD) based on the transcriptomic data of 2,510 patients in 14 independent cohorts, including 12 public datasets and two in-house cohorts. (bvsalud.org)
  • Examination of Abnormal Alpha-synuclein Aggregates in the Enteric Neural Plexus in Patients with Ulcerative Colitis. (nagoya-u.ac.jp)
  • Salivary Gland Polymorphous Adenocarcinoma: Clinicopathological Features and Gene Alterations in 36 Japanese Patients. (nagoya-u.ac.jp)
  • 6. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma. (nih.gov)
  • KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas. (cdc.gov)
  • High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases. (cdc.gov)
  • Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma. (cdc.gov)
  • The provided sections demonstrate an invasive, non-mucinous adenocarcinoma of the lung with a wide range of histologic growth patterns. (cap.org)
  • GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4? (cdc.gov)
  • 4. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens. (nih.gov)
  • In this revised classification, a major update is the introduction of the terms adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA). (cap.org)
  • The pattern-based (Silva) classification of invasive HPV-associated endocervical adenocarcinomas (HPVA) is an established and reproducible method to predict outcomes for this otherwise stage-dependent group of tumors. (stanford.edu)
  • 3. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry. (nih.gov)
  • 13. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer. (nih.gov)
  • Late-stage disease can manifest with pulmonary symptoms, extrapulmonary symptoms, paraneoplastic syndromes (e.g., syndrome of inappropriate antidiuretic hormone secretion , hypercalcemia ), and/or signs of metastatic disease. (amboss.com)
  • 17. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review. (nih.gov)
  • Female genital tract metastasis of lung adenocarcinoma with EGFR mutations: Report of two cases. (cdc.gov)
  • Journal of Thoracic Disease 5:E17-20 Tsao MS, Fraser RS (1991) Primary pulmonary adenocarcinoma with enteric differentiation. (wikipedia.org)
  • 1. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. (nih.gov)
  • 11. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy. (nih.gov)
  • 12. Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases. (nih.gov)
  • 14. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma. (nih.gov)
  • 3.0 cm) adenocarcinoma with growth restricted to neoplastic cells along preexisting alveolar structures (lepidic growth), lacking stromal, vascular or pleural invasion. (cap.org)
  • 9. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma]. (nih.gov)
  • This case first appeared as Performance Improvement Program in Surgical Pathology (PIP) 2013, case 22, and is adenocarcinoma, predominantly acinar type. (cap.org)
  • 18. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy. (nih.gov)
  • Lin D, Zhao Y, Li H, Xing X (2013) Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review. (wikipedia.org)
  • In this study we demonstrate that, after intramuscular injection in chickens, it induces hepatocellular carcinomas of the liver and adenocarcinomas of the kidney. (nih.gov)
  • In 2011, an updated classification of pulmonary adenocarcinoma was issued jointly by the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS) and the European Respiratory Society (ERS). (cap.org)
  • A second major change in the IASLC/ATS/ERS classification is modification of the WHO category of "mixed subtype," which comprised roughly 85% of all lung adenocarcinomas and encompassed a wide variety of tumors with variable prognosis. (cap.org)
  • Molecular Correlates of Invasion Pattern in HPV-Associated Endocervical Adenocarcinoma: Emergence of Two Distinct Risk-Stratified Tiers. (stanford.edu)
  • 2. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. (nih.gov)
  • This type is considered to be rare with fewer than 30 reports in the literature. (wikipedia.org)
  • Age, sex, race/ethnicity, tobacco use, chronic conditions, influenza vaccination, influenza antiviral medication, and influenza type or subtype were included as exposures in logistic regression models, and marginal adjusted risk ratios and 95% CIs were estimated to describe factors associated with aHF or aIHD. (cdc.gov)
  • Malignant transformation describes the phenomenon in which a somatic component of a germ cell teratoma undergoes malignant differentiation. (biomedcentral.com)